drugset / Trial / NCT06842277
Treatment of Deficient Interdental Papilla Using Albumin-platelets Rich Fibrin
NaSingle-groupOpen-labelTreatment
Summary
The goal of this ( A case series, clinical trial ) is treatment of deficient interdental papilla in patients who have interdental papillary loss class 1 or 2 in maxillary or mandibular anterior region with plaque index and gingival index less than 1 and the selected sites had distance between contact point and inter proximal bone crest less than 7mm and probing depth less than 4mm. Hypothesis: Albumin-PRF is an efficient treatment of deficient interdental papilla. The primary outcome ( distance between the contact point and papillary tip will be measured by periodontal probe) The participants will practice good oral hygiene measures
Timeline
- Start
- 2025-02-18
- Primary completion
- 2025-12-30
- Completion
- 2026-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Injectable albumin platelets rich fibrin | Unknown | — | Other |